한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제19권3호
  • /
  • Pages.342-349
  • /
  • 2002
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지

Complete Freund's Adjuvant 투여로 골다공증이 유발된 흰쥐에서 $1{\alpha}$,25 Dihydroxy-vitamin $D_3$가 골흡수에 미치는 영향

Effect of $1{\alpha}$, 25 Dihydroxy-vitamin $D_3$ on Bone Resolution in Complete Freund's Adjuvant-induced Osteoporotic Rats

  • 발행 : 2002.09.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Vitamin D is one of important factors involved in the regulation of bone metabolism. In osteoporosis, the therapeutic effect of vitamin D on the healing process has still been controversial. To conform the effect of $1{\alpha}$, 25 dihydroxy-vitamin $D_3$ on osteoporosis, the change of serum calcium, serum phosphorus, serum alkaline phosphatase, bone mineral density and bone mineral content of osteoporotic tibia were examined comparatively in normal control group(positive control), CFA control(negative control), CFA+$1{\alpha}$, 25 dihydroxy-vitamin $D_3$ 0.01 ug/kg group and CFA+$1{\alpha}$, 25 dihydroxy-vitamin $D_3$ 0.1 ug/kg group after osteoporosis was induced by single injection of complete Freund's adjuvant(CFA) in rats. In change of serum calcium. the significantly increased value was shown on 2nd and 5th week(P< 0.05) after treatment in $1{\alpha}$, 25 dihydroxy-vitamin D$_3$ 0.01 ug/kg group and on 3rd week(P<0.05) after treatment in $1{\alpha}$, 25 dihydroxy-vitamin $D_3$ 0.1 ug/kg group than CFA control. In change of serum phosphorus, the significantly increased value was shown on 2nd week(P<0.05) after treatment in $1{\alpha}$, 25 dihydroxy-vitamin $D_3$ 0.01 ug/kg group and on 3rd and 4th week(P<0.05) after treatment in $1{\alpha}$, ,25 dihydroxy-vitamin $D_3$ 0.1 ug/kg group than CFA control. The value of bone mineral density and bone mineral content of tibia was increased in both $1{\alpha}$,25 dihydroxy-vitamin $D_3$ 0.01 ug/kg group and $1{\alpha}$, 25 dihydroxy-vitamin $D_3$ 0.1 ug/kg group than CFA control, and the increase rate of that was higher in $1{\alpha}$, 25 dihydroxy-vitamin $D_3$ 0.1 ug/kg group than $1{\alpha}$, 25 dihydroxy-vitamin $D_3$ 0.01 ug/kg group. Considering above findings collectively, it was considered that $1{\alpha}$, 25 dihydroxy-vitamin $D_3$ was effective in preventing the complete Freund's adjuvant-induced osteoporotic decrease of bone mass.

키워드

참고문헌

  1. Calcif Tissue Int v.60 no.1 Rationale for active vitamin D analog therapy in senile osteoporosis Akesson K;Lau KHW;Baylink DJ https://doi.org/10.1007/s002239900195
  2. Int J Clin Pract v.52 no.3 Osteoporosis in men Anderson FH
  3. Korean J Vet Res v.39 no.5 Therapeutic effects of 1α,25 dihydroxycholecalciferol on osteoporotic fracture in a rat model Bae CS
  4. Proc Soc exp Biol Med v.145 Adjuvant disease in rats : biochemical criteria for distinguishing several phases of inflammation and arthritis Baumgartner WA;Beck FWJ;Whitehouse MW https://doi.org/10.3181/00379727-145-37863
  5. Acta Phamachol et Toxicol v.59 Bone change in rats with adjuvant arthritis : treatment with 1α-hydroxycholecalciferol Binderup L
  6. Ann Rheum Dis v.42 Decreased T-suppressor cell activity in rats with adjuvant arthritis Binderup L https://doi.org/10.1136/ard.42.6.693
  7. Veterinary medicine, (7th ed.) Diseases of the musculoskeletal system Blood DC;Radostits OM;Henderson JA
  8. Am J Med v.95 no.SUP.5A New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs Brandi ML https://doi.org/10.1016/0002-9343(93)90386-4
  9. Lancet v.338 no.8780 Homocyst(e)inaemia and bone density in elderly women Browner WS;Malinow MR
  10. Eur J Clin Invest v.11 no.4 Effect of 1,25-dihydroxyvitamin $D_3$ in itself or combined with hormone treatment in preventing postmenopausal osteoporosis Christiansen C;Christiansen MS;R ø dbro P;Hagen C;Transb ø l Ⅰ https://doi.org/10.1111/j.1365-2362.1981.tb02121.x
  11. Am J Clin Nutr v.29 Metabolism of vitamin D : current status DeLuca HF
  12. Clin Endocrinol (Oxf) v.48 no.5 Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease Di Somma C;Colao A;Pivonello R;Salvatore M;Lombardi G https://doi.org/10.1046/j.1365-2265.1998.00486.x
  13. J Bone and Mineral Research v.15 no.1 1,25 dihydroxyvitamin $D_3$ as well as its analogue OCT lower blood calcium through inhibition of bone resortion in hypercalcemic rats with continuous parathyroid hormone-related peptide infusion Endo K;Katsumata K;Hirata M;Ikeda K;Ogata E https://doi.org/10.1359/jbmr.2000.15.1.175
  14. Osteoporos Int v.8 Short-term prophylaxis against estrogen depletion-induced bone loss with calcitrol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized reats Erben RG;Bromm S;Stangassinger M https://doi.org/10.1007/s001980050052
  15. Endocrinology v.139 no.10 Therapeutic efficacy of 1α,25-dihydroxyvitamin $D_3$and calcium in osteopenic ovariectomized rats : evidence for a direct anabolic effects of 1α,25-dihydroxyvitamin $D_3$ on bone Erben RG;Bromm S;Stangassinger M https://doi.org/10.1210/en.139.10.4319
  16. Calcif Tissue Int v.50 no.3 Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats Erben RG;Weiser H;Zucker H https://doi.org/10.1007/BF00296287
  17. Textbook of veterinary internal medicine, (4th ed.) Congenital defects of the dog Ettinger SJ;Feldman EC
  18. Acta Med Scand v.221 no.2 Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxy- cholecalciferol Falch JA;Ødegaard OR;Finnanger AM;Matheson I https://doi.org/10.1111/j.0954-6820.1987.tb01267.x
  19. Proc Natl Acad Sci USA v.79 no.10 1,25-dihydroxyvitamin D3: Short- and long-term effects on bone and calcium metabolism in parients with postmenopausal osteoporosis Gallagher JC;Jerpbak CM;Riggs BL https://doi.org/10.1073/pnas.79.10.3325
  20. Metabolism v.39 no.4Suppl1 Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate Gallagher JC;Riggs BL
  21. Ann Intern Med v.111 no.7 Calcitriol for postmenopausal osteoporosis Gallagher JC;Riggs BL
  22. Aging v.10 no.3 Secondary osteoporosis Gennari C;Martini G;Nuti R
  23. J Rheumatol v.25 no.7 Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatiod arthritis Gough A;Sambrook P;Devlin J;Nguyen T;Emery P
  24. Calcif Tissue Int v.61 no.1 Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study Gurlek A;Bayraktar M;Gedik O https://doi.org/10.1007/s002239900291
  25. J Biochem v.94 no.4 1α,25-dihydroxyvitamin $D_3$ induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria Haneji T;Kurihara N; Ikeda K;Kumegawa M https://doi.org/10.1093/oxfordjournals.jbchem.a134456
  26. J Nutr v.126 no.SUP.4 Vitamin D and bone health Holick MF
  27. Drugs Aging v.12 no.SUP.1 Fast and slow bone losers. Relevance to the management of osteoporosis Hough S
  28. Calcif Tissue Int v.61 no.2 Calcitriol and bone mass accumulation in females during puberty Ilich JZ;Badenhop NE;Nagode LA;Matkovic V https://doi.org/10.1007/s002239900304
  29. Clin Orthop v.192 Does $1,25(OH)_2D_3$ accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women Jensen GF;Meinecke B;Boesen J;Transbol I
  30. J Bone Joint Surg v.64B Vitamin D metabolism and its clinical application Kanis JA
  31. Endocrinol Metab Ciln North Am v.27 no.2 The role of fluoride in the prevention of osteoporosis Kleerekoper M https://doi.org/10.1016/S0889-8529(05)70015-3
  32. Osteoporos Int v.12 no.2 Intravenous pamidronate as treatment for osteoporosis after heart transplantation : a prospective study Krieg MA;Seydoux C;Sandini L;Thiebaud D;Burckhardt P https://doi.org/10.1007/s001980170142
  33. Aging v.10 no.5 Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis Kruger MC;Coetzer H;de Winter R;van Papendorp DH
  34. Nippon Rinsho v.56 no.6 Secondary osteoporosis and its treatment-diabetes mellitus Kumeda Y;Inaba M;Nishizawa Y
  35. Bone v.20 Time course of femoral neck osteopenia in ovariectomized rats Li M;Shen Y;Wronski TJ https://doi.org/10.1016/S8756-3282(96)00317-1
  36. Am J Med Sci v.313 no.1 Bisphosphonate therapy Licata AA https://doi.org/10.1097/00000441-199701000-00004
  37. Clinical Orthopedics and Related Res v.160 Effects of 1,25 dihydroxyvitamin $D_3$ and calcitonin on fracture healing in adult rats Lindgren JU;Narechania RG;Lange TA;Deluca HF
  38. Aging v.10 no.3 The role of parathyroid hormone in the pathogenesis, prevention and treatment of postmenopausal osteoporosis Masiukiewicz US;Insogna KL
  39. Annals of the Rheumatic Diseases v.57 no.6 Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women Masud T;Mulcahy B;Keen RW;Doyle DV;Spector TD https://doi.org/10.1136/ard.57.6.346
  40. J Bone Miner Res v.13 no.12 Bone density and fracture risk in man Melton LJ;Atkinson EJ;O'Fallon WM;Riggs BL https://doi.org/10.1359/jbmr.1998.13.12.1915
  41. Bone v.23 no.3 Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency Miller MA;Chin J;Miller SC;Fox J https://doi.org/10.1016/S8756-3282(98)00098-2
  42. Rheumatic Diseases Clinics of North America v.27 no.1 Calcium and vitamin D in osteoporosis Morgan SL https://doi.org/10.1016/S0889-857X(05)70189-7
  43. Scand J Rheumatol no.SUP.107 Heparin-induced osteoporosis Nelson-Piercy C
  44. Maturitas v.30 Osteoporosis : intervention options Netelenbos C https://doi.org/10.1016/S0378-5122(98)00091-7
  45. Nutr Rev v.56 Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women O'Brien KO https://doi.org/10.1111/j.1753-4887.1998.tb01740.x
  46. Aliment Pharmacol Ther v.12 no.1 Sex hormone status and bone metabolism in men with Crohn's disease Robinson RJ;Iqbal SJ;Al-Azzawi F;Abrams K;Mayberry JF https://doi.org/10.1046/j.1365-2036.1998.00271.x
  47. Nippon Naibunpi Gakkai Zasshi v.65 no.11 The effect of $1,25(OH)_2D_3$ on bone mineral content in senile osteoporosis-A dose finding study Shiraki M;Ito H;Orimo H
  48. Am J Med Sci v.313 no.1 Calcitonin Silverman SL https://doi.org/10.1097/00000441-199701000-00003
  49. Clinical Immunol and Immunopathol v.84 no.2 Changes in bone mineral density in rat adjuvant arthritis Takagi T;Tsao PW;Totsuka R;Takata I https://doi.org/10.1006/clin.1997.4373
  50. Presse Med v.27 no.32 Male osteoporosis Treves R;Louer V;Bonnet C;Vergne P;Bertin P
  51. Clin Orthop v.196 1,25 dihydroxyvitamin D3 stimulates alkaline phosphatase activity and inhibits soft tissue proliferation in implants of bone matrix Vukicevic S;Stavlienic A;Bagi C;Winter I
  52. Ther Umsch v.55 no.11 Drug treatment of osteoporosis Ziegler R